EWM
Evercore Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-899
| Closed | -$214K | – | 406 |
|
|
2022
Q4 | $214K | Buy |
+899
| New | +$214K | ﹤0.01% | 381 |
|
|
2018
Q1 | – | Sell |
-600
| Closed | -$76K | – | 370 |
|
|
2017
Q4 | $76K | Hold |
600
| – | – | ﹤0.01% | 511 |
|
|
2017
Q3 | $70K | Hold |
600
| – | – | ﹤0.01% | 524 |
|
|
2017
Q2 | $48K | Hold |
600
| – | – | ﹤0.01% | 579 |
|
|
2017
Q1 | $31K | Hold |
600
| – | – | ﹤0.01% | 678 |
|
|
2016
Q4 | $22K | Hold |
600
| – | – | ﹤0.01% | 737 |
|
|
2016
Q3 | $41K | Hold |
600
| – | – | ﹤0.01% | 639 |
|
|
2016
Q2 | $33K | Sell |
600
-300
| -33% | -$16.5K | ﹤0.01% | 660 |
|
|
2016
Q1 | $57K | Hold |
900
| – | – | ﹤0.01% | 543 |
|
|
2015
Q4 | $84K | Buy |
900
+600
| +200% | +$56K | ﹤0.01% | 501 |
|
|
2015
Q3 | $24K | Hold |
300
| – | – | ﹤0.01% | 704 |
|
|
2015
Q2 | $36K | Hold |
300
| – | – | ﹤0.01% | 687 |
|
|
2015
Q1 | $31K | Hold |
300
| – | – | ﹤0.01% | 706 |
|
|
2014
Q4 | $29K | Hold |
300
| – | – | ﹤0.01% | 618 |
|
|
2014
Q3 | $23K | Hold |
300
| – | – | ﹤0.01% | 713 |
|
|
2014
Q2 | $19K | Hold |
300
| – | – | ﹤0.01% | 742 |
|
|
2014
Q1 | $20K | Buy |
+300
| New | +$20K | ﹤0.01% | 738 |
|